top of page

Optimizing Treatment with Genetic Insights

By considering your genetic factors, we aim to optimize therapeutic outcomes and reduce potential side effects, providing personalized care for each patient.

Genetic Results for Personalized Care

At Atomic Mindworks we specialize in individual medication management by integrating genetic reviews, including assessment of MTHFR, MTRR, MTR, and COMT genes. Understanding a patient's genetic profile allows us to tailor treatments that address specific metabolic pathways, such as those involving homocysteine metabolism.

​

Elevated homocysteine (Hcy) levels have been link to psychiatric disorders such as schizophrenia, depression, and bipolar disorder. A study involving 191 first-episode inpatients aged 18-40 years found that those with psychiatric conditions had significantly higher Hcy levels compared to healthy controls. Notably, male patients exhibited higher Hcy levels across several disorders, including schizophrenia and major depressive disorder. However, no significant differences in Hcy levels were observed among the various psychiatric disorders studied, (Fan et al, 2024).

Homocysteine and
Psychiatric Symptoms

The Effects of Plasma Homocysteine Level on the Risk of Three Major Psychiatric Disorders: A Mendelian Randomization Study

Increased serum homocysteine in first episode and drug-naïve individuals with schizophrenia: sex differences and correlations with clinical symptoms

B12 for Benefits of Lowering Hcy Levels in SCZ and BD

How Ketamine Treats Depression 

This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content.

7412 SW Beaverton Hillsdale Hwy Ste 106

Portland, Oregon 97225​​

​Fax: 866.573.0890 

Monday-Friday 12pm-6pm
Saturday By Appointment Only

  • Instagram
  • Facebook

©2024 Atomic Mindworks, LLC

bottom of page